| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Oct-07 | | Total Revenue | 18,146 | 15,684 | 18,985 | | Cost of Revenue | 1,722 | 1,250 | 1,631 | | | Gross Profit | 16,423 | 14,434 | 17,354 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 313 | 271 | 465 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 16,110 | 14,163 | 16,889 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20,324) | (15,257) | (10,164) | | Earnings Before Interest And Taxes | 16,110 | 12,519 | 16,383 | | Interest Expense | 506 | 119 | 1 | | Income Before Tax | 15,605 | 12,399 | 16,382 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,719) | (1,213) | 6,724 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,719) | (1,213) | 6,724 | | Preferred Stock And Other Adjustments | (1,891) | (3,278) | (4,588) | | | Net Income Applicable To Common Shares | ($6,610) | ($4,491) | $2,137 |
|
0.58% Nasdaq 
Income Statement
